Physician profile

Adeel I Khan

Pulmonary Disease · Washington, MO

NPI 1790993863

$316,111.38

in general payments reported to CMS, 2019-2025

43 companies · $28K in 2025

The $28K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

See the full distribution for Pulmonary Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$128,212.50
Travel and Lodging$7,321.87
Food and Beverage$7,053.08
Education$102.81
Gift$17.21

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $294,674.14 2019-2025 Arexvy, Nucala, Trelegy Ellipta
Boehringer Ingelheim Pharmaceuticals, INC. $5,724.93 2019-2025 Ofev, Stiolto Respimat, Spiriva Respimat
Mylan Specialty L.P. $5,434.81 2019-2024 Yupelri
Intuitive Surgical, INC. $3,772.43 2022-2024
Astrazeneca Pharmaceuticals LP $2,249.73 2019-2025 Fasenra, Airsupra, Tezspire
Viiv Healthcare Company $600.00 2019
Regeneron Healthcare Solutions, INC. $382.11 2021-2025 Dupixent
Electromed, INC. $313.50 2021-2025 Smartvest
Jazz Pharmaceuticals INC. $228.66 2019-2025 Xywav
Genzyme Corporation $222.22 2019-2025
Actelion Pharmaceuticals US, INC. $217.80 2019-2025 Uptravi, Opsumit
United Therapeutics Corporation $199.67 2021-2024 Tyvaso
Grifols USA, LLC $194.46 2021-2025 Prolastin-C Liquid
Harmony Biosciences LLC $178.80 2022-2025 Wakix
Medtronic USA, INC. $175.00 2019
Show all 43 companies
CompanyGeneral paymentsYearsTop products
Inspire Medical Systems, INC. $148.85 2023-2024 Inspire
Genentech USA, INC. $146.87 2019
Ani Pharmaceuticals, INC. $144.87 2023-2025 Purified Cortrophin Gel
Sunovion Pharmaceuticals INC. $134.22 2019
Takeda Pharmaceuticals U.S.A., INC. $130.51 2020-2025 Glassia
Insmed, INC. $104.30 2021-2024 Arikayce
Philips North America LLC $100.86 2019-2024 (8874) Incourage
Avadel Cns Pharmaceuticals, LLC $85.05 2024-2025 Lumryz
Fisher & Paykel Healthcare INC $59.93 2020-2025 Fisher & Paykel Healthcare
Amgen INC. $57.99 2023-2025 Tezspire, Tavneos
Baxter Healthcare $57.23 2022-2023 Hillrom - Vest System Model 105 Home Care
Veloxis Pharmaceuticals, INC. $50.00 2023 Envarsus
Merck Sharp & Dohme LLC $42.08 2021-2023
Resmed Corp $34.39 2021-2023
Ambu INC. $33.68 2021
Conmed Corporation $25.30 2024 Airseal
Ethicon US, LLC $22.29 2024 Vistaseal, Surgicel Nu-Knit, Harmonic
Pulmonx Corporation $21.29 2023 Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter
Shire North American Group INC $19.03 2019
Lilly USA, LLC $17.45 2025 Zepbound
Tactile Systems Technology INC $16.87 2024 Entre Plus, Flexitouch Plus
Paratek Pharmaceuticals, INC. $16.80 2023 Nuzyra
E.R. Squibb & Sons, L.L.C. $14.23 2022
Pfizer INC. $13.57 2021
Novartis Pharmaceuticals Corporation $12.64 2021
Circassia INC. $11.96 2019
Veran Medical Technologies, INC. $11.17 2019-2020
Itamar Medical INC $9.69 2025 Watchpatone

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Adeel I Khan

$316,111.38

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $28K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/354290/adeel-i-khan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.